Immunoglobulin G4-related Hepatopathy after COVID-19 Vaccination

Intern Med. 2023 Jul 15;62(14):2139-2143. doi: 10.2169/internalmedicine.1634-23. Epub 2023 Mar 31.

Abstract

An 84-year-old woman with IgG4-related disease presented with jaundice and liver dysfunction after coronavirus disease 2019 (COVID-19) vaccination. Serum IgG4 levels were elevated. Diagnostic imaging showed no stenotic lesions in the bile ducts. A liver biopsy was performed because of the enlarged liver. Infiltration of IgG4-positive plasma cells, which accounted for approximately 74% of total plasma cells, was found in the portal area, but there was no evidence of periportal hepatitis, and inflammatory cell infiltration into the lobular space was minimal. IgG4-related hepatopathy was diagnosed. The patient achieved spontaneous remission with no treatment and only follow-up and remains under observation at the time of writing.

Keywords: COVID-19 vaccination; IgG4-related hepatopathy.

Publication types

  • Case Reports

MeSH terms

  • Aged, 80 and over
  • COVID-19 Vaccines* / adverse effects
  • COVID-19* / prevention & control
  • Female
  • Humans
  • Immunoglobulin G
  • Immunoglobulin G4-Related Disease* / pathology
  • Liver Diseases* / etiology

Substances

  • COVID-19 Vaccines
  • Immunoglobulin G